berberine has been researched along with 2019 Novel Coronavirus Disease in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Regarding the global coronavirus disease 2019 (COVID)-19 pandemic, kidney clear cell carcinoma (KIRC) has acquired a higher infection probability and may induce fatal complications and death following COVID-19 infection." | 1.91 | Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets. ( Li, X; Liang, W; Nie, K; Wang, X; Yang, F; Zheng, K; Zheng, Y; Zheng, Z, 2023) |
| " An orally available immunotherapeutic-berberine nanomedicine, named NIT-X, has been developed by our group and has shown significantly increased oral bioavailability of berberine, increased IFN-γ production by CD8+ T cells, and inhibition of mast cell histamine release in vivo, suggesting a protective immune response." | 1.62 | A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study. ( Geliebter, J; Huang, W; Li, K; Li, XM; Maskey, AR; Miao, M; Srivastava, K; Tiwari, R; Toutov, AA; Wang, ZZ; Yang, N, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 11 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiNicolantonio, JJ | 1 |
| McCarty, MF | 1 |
| Assanga, SI | 1 |
| Lujan, LL | 1 |
| O'Keefe, JH | 1 |
| Oner, E | 1 |
| Al-Khafaji, K | 1 |
| Mezher, MH | 1 |
| Demirhan, I | 1 |
| Suhail Wadi, J | 1 |
| Belge Kurutas, E | 1 |
| Yalin, S | 1 |
| Choowongkomon, K | 1 |
| Zheng, Z | 1 |
| Li, X | 1 |
| Nie, K | 1 |
| Wang, X | 1 |
| Liang, W | 1 |
| Yang, F | 1 |
| Zheng, K | 1 |
| Zheng, Y | 1 |
| Pizzorno, A | 1 |
| Padey, B | 1 |
| Dubois, J | 1 |
| Julien, T | 1 |
| Traversier, A | 1 |
| Dulière, V | 1 |
| Brun, P | 1 |
| Lina, B | 1 |
| Rosa-Calatrava, M | 1 |
| Terrier, O | 1 |
| Katare, AK | 1 |
| Singh, B | 2 |
| Shukla, P | 1 |
| Gupta, S | 1 |
| Yalamanchili, K | 1 |
| Kulshrestha, N | 1 |
| Bhanwaria, R | 1 |
| Sharma, AK | 1 |
| Sharma, S | 1 |
| Mindala, DP | 1 |
| Roy, S | 1 |
| Kalgotra, R | 1 |
| Fan, TT | 1 |
| Cheng, BL | 1 |
| Fang, XM | 1 |
| Chen, YC | 1 |
| Su, F | 1 |
| Zhang, BY | 1 |
| Chen, M | 1 |
| Chen, XC | 1 |
| Cao, K | 1 |
| You, Y | 1 |
| Qian, YJ | 1 |
| Yu, WK | 1 |
| Varghese, FS | 1 |
| van Woudenbergh, E | 1 |
| Overheul, GJ | 1 |
| Eleveld, MJ | 1 |
| Kurver, L | 1 |
| van Heerbeek, N | 1 |
| van Laarhoven, A | 1 |
| Miesen, P | 1 |
| den Hartog, G | 1 |
| de Jonge, MI | 1 |
| van Rij, RP | 1 |
| Wang, ZZ | 1 |
| Li, K | 1 |
| Maskey, AR | 1 |
| Huang, W | 1 |
| Toutov, AA | 1 |
| Yang, N | 1 |
| Srivastava, K | 1 |
| Geliebter, J | 1 |
| Tiwari, R | 1 |
| Miao, M | 1 |
| Li, XM | 1 |
| Piazza, M | 1 |
| Boner, AL | 1 |
| Girotto, S | 1 |
| Concia, E | 1 |
| Bellanti, JA | 1 |
| Derosa, G | 1 |
| Maffioli, P | 1 |
| D'Angelo, A | 1 |
| Di Pierro, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Remdesivir Versus Remdesivir- Ivermectin Combination Therapy in Severe and Critically Ill Covid-19[NCT04944082] | Phase 4 | 60 participants (Anticipated) | Interventional | 2021-07-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for berberine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity.
Topics: AMP-Activated Protein Kinases; Anthocyanins; Berberine; Coumaric Acids; COVID-19; Humans; Longevity; | 2022 |
Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis.
Topics: Anti-Inflammatory Agents; Artemisinins; Astragalus propinquus; Berberine; Betacoronavirus; Coronavir | 2020 |
Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications.
Topics: Berberine; China; COVID-19; Dietary Supplements; Fatty Acids, Omega-3; Fungal Polysaccharides; Human | 2021 |
8 other studies available for berberine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Investigation of berberine and its derivatives in Sars Cov-2 main protease structure by molecular docking, PROTOX-II and ADMET methods: in machine learning and in silico study.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Berberine; COVID-19; Epstein-Barr Virus Infections; Herp | 2023 |
Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets.
Topics: Berberine; Carcinoma, Renal Cell; COVID-19; Humans; Kidney; Kidney Neoplasms; Molecular Docking Simu | 2023 |
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus | 2020 |
Rapid determination and optimisation of berberine from Himalayan
Topics: Berberine; Berberis; Chromatography, High Pressure Liquid; COVID-19; Humans; Lycium; Plant Extracts; | 2022 |
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Berberine; COVID-19; COVID-19 Drug Treatment; Cytokine R | 2021 |
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.
Topics: Adolescent; Animals; Antiviral Agents; Berberine; Cells, Cultured; Chlorocebus aethiops; COVID-19; E | 2021 |
A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study.
Topics: Administration, Oral; Antiviral Agents; Berberine; Cell Line; Computer Simulation; COVID-19; COVID-1 | 2021 |
Is nutraceutical supplementation appropriate for COVID-19 management?
Topics: Berberine; Catechin; COVID-19; Curcumin; Dietary Supplements; Humans; Lactobacillus; NF-E2-Related F | 2021 |